XML 24 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9
Enterprise-wide Sales Information (Tables)
6 Months Ended
Jan. 31, 2015
Enterprise-wide Sales Information [Abstract]  
Enterprise-wide sales information
The enterprise-wide sales presentation shown below incorporates both the revised presentation and the previous presentation for the three and six months ended January 31, 2015 and 2014, respectively:

  
Three Months
 Ended January
 31, 2015
  
Three Months
 Ended January
 31, 2014
  
Six Months
 Ended January
31, 2015
  
Six Months
 Ended January
 31, 2014
 
Presentation based upon market
       
Net Sales
        
Ophthalmic (1)
 
$
9,985
  
$
9,165
  
$
19,510
  
$
18,129
 
Neurosurgery (2)
  
7,894
   
5,788
   
14,912
   
12,245
 
Other (3)
  
310
   
143
   
414
   
252
 
  
$
18,189
  
$
15,096
  
$
34,836
  
$
30,626
 
Presentation based upon distribution
             
Net Sales
                
Ophthalmic(4)
 
$
8,228
  
$
8,739
  
$
16,958
  
$
17,237
 
OEM (5)
  
9,784
   
6,123
   
17,470
   
12,971
 
Other (6)
  
177
   
234
   
408
   
418
 
Total
 
$
18,189
  
$
15,096
  
$
34,836
  
$
30,626
 
Net Sales
                
Domestic
 
$
12,887
  
$
11,050
  
$
25,041
  
$
22,919
 
International
  
5,302
   
4,046
   
9,795
   
7,707
 
  
$
18,189
  
$
15,096
  
$
34,836
  
$
30,626
 

(1)Net sales from Ophthalmic represent all sales of ophthalmic devices from direct sales representatives, distribution partners and OEMs.  Recognition of deferred revenue of $322,000 and $644,000 from Alcon, Inc. is included in this category for the three and six months ended January 31, 2015 and 2014, respectively.
(2)Net sales from Neurosurgery represent sales of electrosurgery generators, disposable bipolar forceps and related accessories and royalties from Codman, multi-channel generators, disposable ultrasonic tips and related accessories to Stryker and certain neurosurgery disposables sold through distribution.  Many of the products that the Company sells to its neurosurgery OEM customers are shipped to their non-U.S. customers in various countries around the world, but are included in the Company’s domestic revenues.
(3)Other net sales represent all sales of aesthetic devices, and other miscellaneous revenues.
(4)Net sales from Ophthalmic represent sales of ophthalmic devices from direct sales representatives and distribution partners.
(5)Net sales from OEM represent sales of electrosurgery generators, disposable bipolar forceps and related accessories and royalties from Codman, multi-channel generators, disposable ultrasonic tips and related accessories to Stryker and sales of certain disposable products.  Recognition of deferred revenues of $322,000 and $644,000 from Alcon, Inc. is included in this category for the three and six months ended January 31, 2015 and 2014, respectively.  Many of the products that the Company sells to its neurosurgery OEM customers are shipped to their non-U.S. customers in various countries around the world, but are included in the Company’s domestic revenues.
(6)Other net sales represent direct neurosurgery revenues, and other miscellaneous revenues.